Top news from AIDS2020: Virtual
Highlights from the AIDS2020: Virtual conference
Fatty (t)issues
Weight gain and HIV medications
New long-acting drugs in development
Trend towards long-acting HIV medications continues
Taking meds monthly—or possible once a year
A look at drugs in development for HIV treatment and prevention
What's Cooking?
A sneak peak at some of the new drugs coming soon
2020 HIV Drug Chart
A quick guide to the most commonly used HIV medications
HIV Life Cycle
Different drug classes interrupt the virus from replicating at various stages
Choice Options
DHHS Guidelines for people starting HIV therapy for the first time
The Waxing and Waning of HIV Drugs
Medications come and go, but the goal is still the same
Weighty Concerns
What we know for now about weight gain with HIV medications
Contributors
Our 2020 HIV Drug Guide Contributors
Briefly
Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more
The future is already here
Technological advances in HIV treatment and prevention
Briefly
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Exciting news from Mexico City
Fostemsavir; long-acting injectable; vaginal ring
Dolutegravir during pregnancy
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
HIV meds just four days a week?
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Building blocks for a healthy life
Building blocks for a healthy life, with insights from a nurse educator
Briefly
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Editor's Note
Note to my younger self.
Truvada Safety
Talking about PrEP and HIV treatment in a time of class action lawsuits
Briefly
Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; tenofovir class action lawsuits
Healthiness in HIV
A look in the poster hall
Drugs in development
Monthly injections plus inhibitors of viral capsid and maturation
Briefly: May+June 2019
New two-drug regimen gets FDA approval. Transgender filmmaker debuts new documentary. Project Inform closes. First kidney transplant from donor living with HIV.
Find Your 2020 HIV Drug Here
An A to Z listing of the drugs in the 2020 HIV Drug Guide
Coming Attractions
A sneak peak at some of the new drugs coming soon
An Ensemble Cast
How different drug classes play their part in the HIV lifecycle
Your Map to the Stars
Getting the most out of your drug guide
On With the Show!
Moving beyond your diagnosis—finding a provider, knowing your rights, and more
Supporting Role
HIV treatment can be costly, but there’s help
When Drugs Collide!
Understanding drug interactions
Rising to the Occasion
DHHS guideline recommendations for first-time therapy in HIV
And the Nominees Are…
A quick look at the recommendations for first-time therapy
The Conversation: March & April 2019
Mixed emotions for a long-term survivor. Peer education in prison. Loving the HIV drug guides and charts.
Opening Credits
Contributors to the 2019 HIV Drug Guide
Front Cover Backstory: March & April 2019
The experience is your own, but you’re not alone in the room
The road ahead
New drugs, new options on the horizon
Pennies from above
HIV treatment can be costly, but there’s help
Standard practice
DHHS treatment guidelines for first-time HIV therapy
The future of HIV therapy
New strategies are here—and more are on the way, says W. David Hardy, MD